New tools and methods are empowering both patients and providers to make an effective choice of asthma treatment

• The decision and conversation aid for mild asthma were developed through a scientific process and through engagement with asthma patients and primary care providers, and in accordance with all qualifying and certifying criteria
• The goal of these newly developed tools is to help patients and providers to achieve that “shared decision making” in real practice
• Research reveals that open discussions can help patients and providers to reach shared treatment decisions that are based on both scientific evidence and individual patient goals and preferences
• “In the real world of busy clinics, lack of time and lack of practical resources to support conversations with patients make this hard to achieve,”

Dr. Myriam Gagné

Postdoctoral Fellow

EHealth Knowledge Translation Research Group

Click here to learn more.

About SVMPharma

SVMPharma is an innovative strategic consultancy and CRO, with a focus in Real World Evidence (RWE) for pharmaceutical and biotechnology companies. SVMPharma delivers clinical trials within UK and Europe.

About DISTILL

DISTILL is a new EDC launched by SVMPharma. As a CRO discover the benefits of DISTILL as part of your service offering and take back control of your clinical trials. DISTILL allows you to develop and manage every aspect of your trials from start to finish. Move away from the restrictions and costs associated with legacy systems.

For more information, please visit www.svmpharma.com and contact us at enquiry@svmpharma.com

Ref:RWEMAR2022HBF